Organization PAH. Plan of action for cervical cancer prevention and control 2018–2030. Washington, D.C.: PAHO; 2018.
WHO. International agency of research on cancer. Cervix uteri, Globocan 2020, 2021. p. 1–2.
Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16(32):41–9. https://doi.org/10.1016/S0968-8080(08)32415-X.
WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020–2030, vol. 2, no. 1. 2020.
Baldwin S, Santos C, Brown EM, Nuno T, Giuliano A, John Davis J, et al. Comparison of type-specific human papillomavirus data from self and clinician directed sampling. Gynecol Oncol. 2005;97:612–7.
Berner A, Hassel SB, Tebeu PM, Untiet S, Fosso GK, Navarria I, et al. Human papillomavirus self-sampling in Cameroon: women’s uncertainties over the reliability of the method are barriers to acceptance. J Low Genit Tract Dis. 2013;17(3):235–41.
Flores CEF, Gutierrez GG, Leon JMO, Rodriguez DC, Sørbye SW. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests. BMC Infect Dis. 2021;21(1):1–9.
Schmeink CE, Bekkers RLM, Massuger LFAG, Melchers WJG. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol. 2011;21(3):139–53.
Bergengren L, Kaliff M, Larsson GL, Karlsson MG, Helenius G. Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women. Int J Gynecol Obstet. 2018;142(3):359–64.
Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The acceptability of self-sampled screening for HPV DNA: A systematic review and meta-analysis. Sex Transm Infect. 2017;93(1):56–61.
Polmana NJ, de Haana Y, Veldhuijzen NJ, Heideman DAM, de Vet HCW, Meijer CJLM, et al. Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands. Prev Med. 2019;125:5–11.
Mulki AK, Withers M. Human Papilloma Virus self—sampling performance in low—and middle—income countries. BMC Womens Health. 2021;21:12.
Addis Ababa Health Bureau. Health Sector Transformation Plan II HSTPII 2020–2024.
Bogale AL, Teklehaymanot T, Kassie GM, Medhin G, Ali JH, Belay NB. Performance of visual inspection with acetic acid for cervical cancer screening as compared to human papillomavirus deoxyribonucleic acid testing among women with HIV in Ethiopia: a comparative cross-sectional study. Cancer Control. 2022;29:1–7. https://doi.org/10.1177/10732748221114980.
Altman D. Practical statistics for medical research. London: Chapman and Hall; 1991.
Onuma T, Kurokawa T, Shinagawa A, Chino Y, Yoshida Y. Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection. Int J Clin Oncol. 2020;25(10):1854–60.
Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–6.
Phoolcharoen N, Kantathavorn N, Krisorakun W, et al. Acceptability of self-sample human papillomavirus testing among Thai women visiting a colposcopy clinic. J Community Health. 2018;43:611–5. https://doi.org/10.1007/s10900-017-0460-2.
Chatzistamatiou K, Vrekoussis T, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, Pasentsis K, et al. Acceptability of self-sampling for human papillomavirus-based cervical cancer screening. J Womens Health (Larchmt). 2020;29(11):1447–56. https://doi.org/10.1089/jwh.2019.8258.
Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k4823. https://doi.org/10.1136/bmj.k4823.
Inturrisi F, Aitken CA, Melchers WJG, Molijn A, Hinrichs JWJ, Niesters HGM, et al. Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: an observational study. Lancet Reg Health Europe. 2021;11:100235.
Kuriakose S, Sabeena S, Binesh D, Abdulmajeed J, Ravishankar N, Ramachandran A, et al. Diagnostic accuracy of self-collected vaginal samples for HPV DNA detection in women from South India. Int J Gynecol Obstet. 2020;149(2):219–24.
Yeboah DO, Sarkodie YA, Djigma F, Benjamin AH, Abdul L, Simpore J, et al. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women. BMC Womens Health. 2017;17(1):1–6.
Ketelaars PJW, Bosgraaf RP, Siebers AG, Massuger LFAG, van der Linden JC, Wauters CAP, et al. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: results of the VERA study. Prev Med (Baltim). 2017;101:96–101.
Ajenifuja OK, Ikeri NK, Adeteye OV, Banjo AA. Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility. Pan Afr Med J. 2018;30:1–7.
Katanga JJ, Rasch V, Manongi R, Pembe AB, Mwaiselage JD, Kjaer SK. Concordance in HPV detection between self-collected and health provider-collected cervicovaginal samples using careHPV in Tanzanian women. JCO Glob Oncol. 2021;7:985–91.
Haile EL, Cindy S, Ina B, Jean-Pierre BJPV, Sharon R, Lisbeth LR. HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia. Med (Baltim). 2019;98:35.
Jede F, Brandt T, Gedefaw M, Wubneh SB, Abebe T, Teka B, et al. Home-based HPV self-sampling assisted by a cloud-based electronic data system: lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia. Papillomavirus Res. 2020;9:1001989.
OECD guidelines for quality assurance in molecular genetic testing. 2007, p. 1–38.
Madej RM, Davis J, Holden MJ, Kwang S, Labourier E, Schneider GJ. International standards and reference materials for quantitative molecular infectious disease testing. J Mol Diagn. 2010;12:133–43. https://doi.org/10.2353/jmoldx.2010.090067.
Gupta S, Palmer C, Bik EM, Cardenas JP, Nuñez H, Kraal L, et al. Self-sampling for human papillomavirus testing: increased cervical cancer screening participation and incorporation in international screening programs. Front Public Health. 2018;6:77. https://doi.org/10.3389/fpubh.2018.00077.
Abulizi G, Li H, Mijiti P, Abulimiti T, Cai J, Gao J, et al. Risk factors for human papillomavirus infection prevalent among Uyghur women from Xinjiang, China. Oncotarget. 2017;8(58):97955–64.
Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Ying HuS, Zhang X, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst. 2012;104(3):178–88.
Eshetu AK, Mohammed IA, Difabachew MN, ten Hove RJ, Kumssa TH, Woldu ZL, et al. Burden and genotype distribution of high- risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis. BMC Cancer. 2019;19:768. https://doi.org/10.1186/s12885-019-5953-1.
Ebba A, Abrham A, Muntasir EH, Ibrahim EH, Laerence Y, Wude M, et al. Genotyping of human papilloma virus in paraffin embedded cervical tissue samples from women in Ethiopia and Sudan. J Med Virol. 2013;85:282–7.
Bakiewicz A, Rasch V, Mwaiselage J, Linde DS. the best thing is that you are doing it for yourself’—perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study. BMC Womens Health. 2020;20(1):1–9.
Dzuba IG, Díaz EY, Allen B, Leonard YF, Ponce ECL, Shah KV, et al. The acceptibility of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Women’s Heal Gender-Based Med. 2002;11(3):265–75.
Esber A, Norris A, Jumbe E, Kandodo J, Nampandeni P, Reese PC, et al. Feasibility, validity and acceptability of self-collected samples for human papillomavirus (HPV) testing in rural Malawi. Malawi Med J. 2018;30(2):61–6.
Scarinci IC, Litton AG, Garcés-Palacio IC, Partridge EE, Castle PE. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Women’s Heal Issues. 2013;23(2):123–30.
El-Zein M, Bouten S, Louvanto K, Gilbert L, Gotlieb WH, Hemmings R, et al. Predictive value of Hpv testing in self-collected and clinician-collected samples compared with cytology in detecting high-grade cervical lesions. Cancer Epidemiol Biomark Prev. 2019;28(7):1134–40.
Nishimura H, Yeh PT, Oguntade H, Kennedy CE, Narasimhan M. HPV self-sampling for cervical cancer screening: a systematic review of values and preferences. BMJ Glob Heal. 2021;6(5):1–14.
Dannecker C, Siebert U, Thaler CJ, Kiermeir D, Hepp H, Hillemanns P. Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. Ann Oncol. 2004;15(6):863–9.
Safaeian M, Kiddugavu M, Gravitt P, Ssekasanvu J, Murokora D, Sklar M, et al. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sex Transm Dis. 2007;34(7):429–36.
Daponte A, Michail G, Daponte AI, Daponte N, Valasoulis G. Urine hpv in the context of genital and cervical cancer screening—an update of current literature. Cancers (Basel). 2021;13(7):1–15.